CXorf66
Uncharacterized protein CXorf66
Also known as: CX066_HUMAN, RP11-35F15.2, SGPX
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5JRM2
- Gene
- CXorf66
- Ensembl
- ENSG00000203933
- Chromosome
- X
- Canonical length
- 361 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Perinuclear theca,Calyx,Mid piece,Principal piece,End piece,Annulus
OverviewNCBI Gene
The protein encoded by this gene is predicted to be a type I membrane protein, however, its exact function is not known. [provided by RefSeq, Sep 2009]
Canonical amino-acid sequenceUniProt
361 residues, UniProt reviewed canonical sequence.
>Q5JRM2|CXorf66
1 MNLVICVLLL SIWKNNCMTT NQTNGSSTTG DKPVESMQTK LNYLRRNLLI LVGIIIMVFV
61 FICFCYLHYN CLSDDASKAG MVKKKGIAAK SSKTSFSEAK TASQCSPETQ PMLSTADKSS
121 DSSSPERASA QSSTEKLIRP SSLQKPSIPN SAGKLTRPSY PKRSSKSSCS KKLSKSSHLE
181 KAHKKGSLEK LCKLDYACKL ASSDKPVRPP QLFKPLYSSH PQNEISPSKP FGPQELAKPP
241 KHFNPKRSVS LGRAALLSNS ELAETCQPYK KKHLVAKTYR PLVNDISEAK EKNTQNLHVS
301 SKVKSSSRSF RKLDSRNNAY GDHVNDSDTM KYYSEVDSDK VIIITCDRGY NQVTSEVTLN
361 DLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CXorf66 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.7
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- testis: 13 nTPM
- liver: 0.5 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
- appendix: 0 nTPM
Single-cell type
- early spermatids: 135 nCPM
- late primary spermatocytes: 96 nCPM
- late spermatids: 16 nCPM
- leydig cells: 0.5 nCPM
- sertoli cells: 0.3 nCPM
- cardiomyocytes: 0.1 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.85
- gnomAD pLI
- 0.03
- gnomAD missense Z
- 0.2
- DepMap mean gene effect
- 0.19
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 1% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Uncharacterized protein CXorf66
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CXorf66 as an antibody target. Whether an autoantibody or antibody against CXorf66 could matter depends on whether native CXorf66 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CXorf66 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CXorf66 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...